Janakan Krishnarajah

502 total citations
10 papers, 279 citations indexed

About

Janakan Krishnarajah is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Janakan Krishnarajah has authored 10 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Janakan Krishnarajah's work include Cardiomyopathy and Myosin Studies (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Opioid Use Disorder Treatment (2 papers). Janakan Krishnarajah is often cited by papers focused on Cardiomyopathy and Myosin Studies (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Opioid Use Disorder Treatment (2 papers). Janakan Krishnarajah collaborates with scholars based in Australia, United States and Germany. Janakan Krishnarajah's co-authors include Patrick F. Smith, Mohammad R. Masjedizadeh, Danny Tam, Dane E. Karr, Helen Keen, Gerald F. Watts, Philip A. Nunn, Jens Oliver Funk, Timothy R. Bates and Joanne Marjason and has published in prestigious journals such as Gastroenterology, Annals of the Rheumatic Diseases and British Journal of Clinical Pharmacology.

In The Last Decade

Janakan Krishnarajah

10 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janakan Krishnarajah Australia 8 76 71 57 56 48 10 279
Júlia Kurkó United States 9 73 1.0× 35 0.5× 13 0.2× 16 0.3× 12 0.3× 10 475
Shoichi Koizumi Japan 9 157 2.1× 31 0.4× 98 1.7× 8 0.1× 24 0.5× 14 444
Szymon Zmorzyński Poland 9 119 1.6× 29 0.4× 22 0.4× 33 0.6× 9 0.2× 39 277
J A Kohler United Kingdom 9 98 1.3× 40 0.6× 53 0.9× 12 0.2× 20 0.4× 16 316
Cecilia Vagaggini Italy 6 61 0.8× 14 0.2× 33 0.6× 18 0.3× 14 0.3× 6 297
Eiju Negoro Japan 11 136 1.8× 40 0.6× 38 0.7× 58 1.0× 21 0.4× 39 318
A Wilisch Germany 11 103 1.4× 18 0.3× 34 0.6× 13 0.2× 54 1.1× 15 434
Julia Driesen Germany 11 103 1.4× 44 0.6× 11 0.2× 63 1.1× 19 0.4× 16 578
Pengcheng Shi China 12 155 2.0× 10 0.1× 31 0.5× 28 0.5× 20 0.4× 33 329
Ariadna González‐del Angel Mexico 13 182 2.4× 39 0.5× 14 0.2× 32 0.6× 15 0.3× 65 420

Countries citing papers authored by Janakan Krishnarajah

Since Specialization
Citations

This map shows the geographic impact of Janakan Krishnarajah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janakan Krishnarajah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janakan Krishnarajah more than expected).

Fields of papers citing papers by Janakan Krishnarajah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janakan Krishnarajah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janakan Krishnarajah. The network helps show where Janakan Krishnarajah may publish in the future.

Co-authorship network of co-authors of Janakan Krishnarajah

This figure shows the co-authorship network connecting the top 25 collaborators of Janakan Krishnarajah. A scholar is included among the top collaborators of Janakan Krishnarajah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janakan Krishnarajah. Janakan Krishnarajah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Manoff, Susan B., Jason Martin, David Radley, et al.. (2018). Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults. Human Vaccines & Immunotherapeutics. 15(9). 2195–2204. 52 indexed citations
2.
Schug, Stephan A., et al.. (2017). The Pharmacokinetics and Local Tolerability of a Novel Sublingual Formulation of Buprenorphine. Pain Medicine. 20(1). 143–152. 11 indexed citations
3.
Gavin, Paul, Lee S. Simon, Thomas G. Schlagheck, Alisha J Smith, & Janakan Krishnarajah. (2017). A Phase I Study of the Pharmacokinetics, Safety and Tolerability of a Novel Tocopheryl Phosphate Mixture/Oxymorphone Transdermal Patch System. Pain Management. 7(6). 499–512. 1 indexed citations
4.
Smith, Patrick F., Janakan Krishnarajah, Philip A. Nunn, et al.. (2017). A phase I trial of PRN1008, a novel reversible covalent inhibitor of Bruton's tyrosine kinase, in healthy volunteers. British Journal of Clinical Pharmacology. 83(11). 2367–2376. 76 indexed citations
5.
6.
Krishnarajah, Janakan, Stephen Lillioja, Joanne Marjason, et al.. (2015). Efficacy and safety of beloranib for weight loss in obese adults: a randomized controlled trial. Diabetes Obesity and Metabolism. 17(6). 566–572. 50 indexed citations
7.
Smith, Patrick F., Janakan Krishnarajah, Ronald J. Hill, et al.. (2015). SAT0232 A Phase 1 Clinical Trial of PRN1008, an Oral, Reversible, Covalent BTK Inhibitor Demonstrates Clinical Safety and Therapeutic Levels of BTK Occupancy Without Sustained Systemic Exposure. Annals of the Rheumatic Diseases. 74. 742–742. 8 indexed citations
8.
Keen, Helen, Janakan Krishnarajah, Timothy R. Bates, & Gerald F. Watts. (2014). Statin myopathy: the fly in the ointment for the prevention of cardiovascular disease in the 21st century?. Expert Opinion on Drug Safety. 13(9). 1227–1239. 31 indexed citations
9.
Pelin, Katarina, Maaret Ridanpää, Kati Donner, et al.. (1998). Refined localisation of the genes for nebulin and titin on chromosome 2q allows the assignment of nebulin as a candidate gene for autosomal recessive nemaline myopathy.. PubMed. 5(4). 229–34. 26 indexed citations
10.
Pelin, Katarina, Maaret Ridanpää, Kati Donner, et al.. (1997). Refined Localisation of the Genes for Nebulin and Titin on Chromosome 2q Allows the Assignment of Nebulin as a Candidate Gene for Autosomal Recessive Nemaline Myopathy. European Journal of Human Genetics. 5(4). 229–234. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Júlia Kurkó Breakdown of academic impact, for papers by Shoichi Koizumi Breakdown of academic impact, for papers by Szymon Zmorzyński Breakdown of academic impact, for papers by J A Kohler Breakdown of academic impact, for papers by Cecilia Vagaggini Breakdown of academic impact, for papers by Eiju Negoro Breakdown of academic impact, for papers by A Wilisch Breakdown of academic impact, for papers by Julia Driesen Breakdown of academic impact, for papers by Pengcheng Shi Breakdown of academic impact, for papers by Ariadna González‐del Angel
Rankless by CCL
2026